InvestorsHub Logo
Followers 10
Posts 1242
Boards Moderated 0
Alias Born 12/07/2006

Re: art2426 post# 139739

Tuesday, 05/29/2018 10:14:25 AM

Tuesday, May 29, 2018 10:14:25 AM

Post# of 330280
If we get cleared for Post surgical use, BIEL needs to market to high volume surgeons. Hell, insurance companies should be clamoring for the prescribing of ActiPatch to lower healthcare utilization. As an example, I used to go to the doctor for lateral epicondylitis and shoulder bursitis/tendonitis. I would have a GP Dr visit resulting in an xray and NSAID prescription and then a second visit to get a referal to an Ortho doc. The ortho doc does an xray also plus an aircast (for elbow) and a script for 4 weeks of phyical therapy. In some cases an MRI is ordered. Then a painful injection into the elbow or shoulder. These were both chronic issues, look at the cost of those visits. I have NEVER had another doctor visit for shoulder or elbow issues in the many years that I have used the ActiPatch. That is some serious cost savings right there. I wonder how many other visits for knee, wrist and back that I have preempted with the sweet little gizmo called Actipatch. This is how you combat the opioid problem and spiraling healthcare costs.